Hudson Bay Capital Management Portfolio holdings
AUM
$15.2B
1-Year Return
11.47%
This Quarter Return
+2.33%
1 Year Return
+11.47%
3 Year Return
+62.45%
5 Year Return
+105.91%
10 Year Return
+214.7%
AUM
$14.5B
AUM Growth
+$1.18B
(+8.9%)
Cap. Flow
-$1.03B
Cap. Flow
% of AUM
-7.13%
Top 10 Holdings %
Top 10 Hldgs %
39.46%
Holding
920
New
210
Increased
129
Reduced
179
Closed
219
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
+$430M |
| 2 |
Advanced Micro Devices
AMD
|
+$313M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$265M |
| 4 |
Coinbase
COIN
|
+$199M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$198M |
Top Sells
| 1 |
Apple
AAPL
|
+$286M |
| 2 |
Eli Lilly
LLY
|
+$275M |
| 3 |
Brookfield
BN
|
+$270M |
| 4 |
Amazon
AMZN
|
+$228M |
| 5 |
Home Depot
HD
|
+$158M |
Sector Composition
| 1 | Technology | 29.84% |
| 2 | Financials | 10.86% |
| 3 | Consumer Discretionary | 8.91% |
| 4 | Communication Services | 8.63% |
| 5 | Healthcare | 6.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
451
Nasdaq
NDAQ
$54.6B
| $1.21M | ﹤0.01% |
+16,556
| New | +$1.21M |
|
452
Rocket Pharmaceuticals
RCKT
$351M
| $1.2M | ﹤0.01% |
+65,000
| New | +$1.2M |
|
|
GAP
453
The Gap, Inc.
GAP
$8.95B
| $1.19M | ﹤0.01% |
+54,193
| New | +$1.19M |
|
454
Oak Woods Acquisition Corp
OAKU
$63.2M
| $1.17M | ﹤0.01% |
105,000
| – | – |
|
455
Viatris
VTRS
$12B
| $1.16M | ﹤0.01% |
100,000
-70,000
| -41% | -$813K |
|
|
DIST
456
DELISTED
Distoken Acquisition Corp
DIST
| $1.14M | ﹤0.01% |
+104,449
| New | +$1.14M |
|
|
ONC
457
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.5B
| $1.12M | ﹤0.01% |
5,000
-20,000
| -80% | -$4.49M |
|
458
Pliant Therapeutics
PLRX
$103M
| $1.12M | ﹤0.01% |
100,000
| – | – |
|
|
MARX
459
DELISTED
Mars Acquisition Corp. Ordinary Shares
MARX
| $1.11M | ﹤0.01% |
+100,000
| New | +$1.11M |
|
460
Edgewise Therapeutics
EWTX
$1.55B
| $1.07M | ﹤0.01% |
+39,937
| New | +$1.07M |
|
461
Maravai LifeSciences
MRVI
$379M
| $1.06M | ﹤0.01% |
127,397
-345,396
| -73% | -$2.87M |
|
462
Arcturus Therapeutics
ARCT
$498M
| $1.02M | ﹤0.01% |
+44,000
| New | +$1.02M |
|
|
CUBWU
463
Lionheart Holdings Unit
CUBWU
$248M
| $1.02M | ﹤0.01% |
100,000
| – | – |
|
464
Atkore
ATKR
$2.05B
| $1.02M | ﹤0.01% |
12,000
-4,110
| -26% | -$348K |
|
465
Denali Therapeutics
DNLI
$2.16B
| $1M | ﹤0.01% |
34,500
-140,500
| -80% | -$4.09M |
|
466
Korro Bio
KRRO
$345M
| $1M | ﹤0.01% |
+30,000
| New | +$1M |
|
|
SLRN
467
DELISTED
ACELYRIN
SLRN
| $986K | ﹤0.01% |
+200,000
| New | +$986K |
|
468
Immunome
IMNM
$796M
| $978K | ﹤0.01% |
+66,864
| New | +$978K |
|
469
FedEx
FDX
$53.7B
| $972K | ﹤0.01% |
3,550
-41,955
| -92% | -$11.5M |
|
470
Service Corp International
SCI
$11B
| $960K | ﹤0.01% |
12,167
-173,971
| -93% | -$13.7M |
|
|
CNH
471
CNH Industrial
CNH
$14.1B
| $944K | ﹤0.01% |
+85,000
| New | +$944K |
|
472
Suncor Energy
SU
$51.1B
| $923K | ﹤0.01% |
+25,000
| New | +$923K |
|
473
Celestica
CLS
$28.3B
| $920K | ﹤0.01% |
18,000
-71,468
| -80% | -$3.65M |
|
|
ARDT
474
Ardent Health, Inc.
ARDT
$1.88B
| $881K | ﹤0.01% |
+47,911
| New | +$881K |
|
475
Soleno Therapeutics
SLNO
$3.23B
| $869K | ﹤0.01% |
17,220
-12,780
| -43% | -$645K |
|